Enforcement Analysis
Each week we take one recent FDA warning letter and work through it the way a quality unit should: what the observation actually said, what the firm proposed in its Form 483 response, why FDA found that response inadequate, and what a defensible answer would have required.
Every issue ends with a short diagnostic you can apply to your own open responses.
“You have unsuccessfully attempted similar corrective actions in the past” — when your CAPA history becomes the finding
A firm listed its prior corrective actions to demonstrate diligence. FDA read the same list as proof its CAPA system could not detect its own ineffectiveness.
“The operator didn’t follow procedure” — why that sentence cost one firm a warning letter
Three findings, three attributions to individual error, three rejections. The firm’s own written procedure had directed the behaviour it blamed on the analyst.
Veritas Quality Consultants works with pharmaceutical, medical device, and biologics manufacturers on Form 483 responses, root cause analysis, and CAPA development — built to FDA expectations inside the 15-day window.
Request a consultation